84% of Hyderabad IT Professionals Suffer from Fatty Liver Disease: Nadda Raises Alarm

New Delhi— A staggering 84% of IT employees in Hyderabad have been diagnosed with Metabolic Dysfunction‑Associated Fatty Liver Disease (MAFLD), Union Health Minister J.P. Nadda revealed in the Lok Sabha. One-third of the affected workforce also shows signs of metabolic syndrome, a condition linked to obesity, diabetes, and cardiovascular disease

Silent Epidemic Among Hyderabad’s Tech Workforce

The alarming statistics stem from a study conducted by the University of Hyderabad, which evaluated 345 IT professionals between July 2023 and July 2024 using FibroScan-based liver fat measurement and metabolic risk profiling. The findings:

290 employees (84%) showed elevated liver fat consistent with MAFLD

  • 71% were obese
  • 39% were good

What Causes It?

Experts attribute the crisis to prolonged sitting, high stress levels, irregular sleep, and poor diet prevalent in the tech work culture. These lifestyle factors act as catalysts for metabolic dysfunction and liver fat accumulation

MAFLD—formerly known as non-alcoholic fatty liver disease—is defined by over 5% liver fat, often linked to metabolic risk factors such as insulin resistance, obesity, and dyslipidemia. Left unchecked, it can progress to cirrhosis, liver cancer, or liver failure

Government Response

In response, Nadda called MAFLD a “silent epidemic” and endorsed preventive strategies under the National Programme for NCDs, including:

Pan-India awareness campaigns led by FSSAI

A 5-minute “Yoga Break” protocol introduced by the Ministry of AYUSH to encourage brief workplace activity and stress relief

State-level screening initiatives and early intervention systems

Why This Matters

Hyderabad’s IT sector is central to India’s economic engine, employing over 5 million professionals. High MAFLD prevalence suggests that sedentary office culture, combined with uncontrolled diet and stress, is jeopardising employee health nationwide.

Healthcare experts underscore the urgency for lifestyle modification, regular liver screening, and corporate wellness policies.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework